HILESTROL™ 100% (BPF™) improves overall biomarkers of hyperlipemia via reduction of serum cholesterol, triglicerydes, LDL (the “bad” cholesterol) and small dense lipoproteins and increase of HDL (the “good” cholesterol). BPF™ exerts also positive effect in the maintenance of normal serum glucose concentrations by reducing insuline-resistance.
High cholesterol represents the most relevant risk factor for developing Coronary Artery Disease and Stroke. Current Pharmacological Treatment of High Cholesterol is effective in reducing Cardiovascular Risk but is ac- companied by relevant side effects.
High cholesterol represents the most relevant risk factor for developing coronary artey disease and Stroke. Current Pharmacological treatment of high cholesterol is effective in reducing cardiovascular Risk but is accompanied by relevant side effects.
High cholesterol represents the most relevant risk factor for developing coronary artey disease and Stroke. Current Pharmacological treatment of high cholesterol is effective in reducing cardiovascul